A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies
Clinical trial NCT07532746 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07532746
- Sponsor
- Kousai Bio Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-12-31
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.